Drupal.behaviors.print = function(context) {window.print();window.close();}>
Saladax, CESAR Partner on Study of 5-FU Dosing for Colorectal Cancer
February 13, 2012
Saladax, CESAR Partner on Study of 5-FU Dosing for Colorectal Cancer
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Study Shows Aspirin Could Increase Survival in Colorectal Cancer Patients with PIK3CA Mutations
November 28, 2012 / Pharmacogenomics Reporter
Saladax, Bristol-Myers Squibb Expand Relationship
August 6, 2012 / GenomeWeb Daily News
TCGA's Colorectal Cancer Analysis Marks a Number of New Drug Targets
July 18, 2012 / Pharmacogenomics Reporter
Eilaf Distributing Saladax's My5-FU Test in Egypt, Other Parts of Middle East
April 23, 2012 / GenomeWeb Daily News
Saladax Signs on InyDia Labs to Distribute My5-FU in Spain, Portugal
March 12, 2012 / GenomeWeb Daily News